@checarinitos
Account based inEcuador!
About this account
- Account based in
- Ecuador
- Connected via
- Ecuador App Store
X says this location may be affected by a proxy or VPN.
Account-level information from X, not a live location or the device used for a specific post.
Pichincha, Ecuador
Joined June 2014
- Tweets28.7K
- Following670
- Followers191
- Likes195
Carlos Eugenio retweeted
New in #practicalRO: Multi-Course Reirradiation in Diffuse Intrinsic Pontine Glioma. #radonc bit.ly/4hlesQ3
Carlos Eugenio retweeted
📌 8th International Consensus Guidelines for the management of advanced breast cancer (ABC8 Guidelines)
🔗 thebreastonline.com/article/…
@OncoAlert #OncoAlertAF @hoperugo @Prof_Nadia_H @nlinmd @RebeccaDSing @TanjaSpanic @TheBreastOnline #breastcancer
🔹Updated definition of endocrine sensitivity/resistance, in collaboration with the AURORA Molecular Screening Initiative.
🔸Updated treatment guidelines and algorithms for ER+/HER-2 negative, HER-2+ and triple negative advanced breast cancer.
🔹New guidelines on clinical trials, exercise and artificial intelligence.
🔸Updated guidelines for biomarkers, inflammatory breast cancer, brain imaging and supportive care.
Carlos Eugenio retweeted
New in #practicalRO: When Standard Craniospinal Irradiation Leads to Severe Brainstem Toxicity: An M&M Case of Pineoblastoma in 22q11.2 Deletion Syndrome. #radonc bit.ly/46Pw1ma
Carlos Eugenio retweeted
Hello #radonc X! Wanted to share a little Contouring station vibecoded amidst all this AI craze. Just releases for now, source will be available when I get a grasp of how Github works
github.com/glazcano/ivcs-rad…
@5_utr @SprakerMDPhD @jryckman3 @NiuSanford @VedangMurthy @TylerSbrt
Carlos Eugenio retweeted
📍¿Te interesa la formación en tumores digestivos?
Ya en marcha la III edición del Aula Virtual en Tumores Digestivos @GrupoTTD, con contenidos actualizados y nuevas acreditaciones.
✅Especialistas 'top'
✅12 cursos
🌐aulavirtualttd.es
Stay tuned!
#TTDUpdates
Carlos Eugenio retweeted
🔴Online now: Chemoradiotherapy versus short-course radiotherapy for response-adapted organ preservation in early-stage and intermediate-stage rectal cancer (STAR-TREC): 12-month results of a randomised, phase 2/3 trial
📉thelancet.com/journals/lanon…
&
✏️thelancet.com/journals/lanon…
Carlos Eugenio retweeted
🇧🇷 EL PRESIDENTE DE LA SOCIEDAD BRASILEIRA DE RADIOTERAPIA, EN ALATRO 2026!
El Dr. Wilson De Almeida, actual Presidente de la Sociedade Brasileira de Radioterapia (SBRT), será uno de nuestros invitados internacionales en el X Congreso ALATRO 2026
alatrolatam.org/congreso2026
IASLC Full Membership could be available to you at no cost.
Eligible professionals can access education, global networking, conference discounts, leadership opportunities, and more.
See if you’re eligible: bit.ly/3T70Yip
#LungCancer #ThoracicOncology
Carlos Eugenio retweeted
Radiation oncology practices are getting larger—but what does consolidation mean for physicians and patients?
Alexys Gayne examines changes in practice size and organization, including the movement toward larger groups and academic centers. While consolidation may support coordination and standardization, its effects on cost, access, quality, and the patient experience remain understudied.
Read the latest ARO Student Scan: zurl.co/8blvO
#RadOnc #RadiationOncology #CancerCare
Carlos Eugenio retweeted
New in #practicalRO: Simulation-Free Single-Fraction High-Dose Radiotherapy for Non-Spine Bone and Soft Tissue Metastases. #radonc tinyurl.com/projjavor
Carlos Eugenio retweeted
Can short-course radiotherapy followed by chemotherapy deliver durable survival benefits for patients with locally advanced rectal cancer.
Article 👉 buff.ly/GIcbUqv
Five-Year Outcomes of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy for Locally Advanced Rectal Cancer: Updated Results of the STELLAR Trial💫
The 5-year STELLAR trial results show that short-course radiotherapy☢️ followed by chemotherapy🧪 as total neoadjuvant therapy (TNT) offers a durable overall survival benefit compared with standard long-course chemoradiotherapy in locally advanced rectal cancer.
Although disease-free survival, distant metastasis, and locoregional recurrence were similar, TNT significantly improved overall survival, particularly in high-risk patients, and outcomes after recurrence, supporting TNT as an effective alternative to conventional CRT.
@CathyEngMD
@BenWestphalen
@graokane
@NiuSanford
@AndresC27622123
@GillSharlene
@pashtoonkasi
@DrVilmaPBarcia
@Erman_Akkus
@GIMedOnc
@UOzkerim
@MarioBalsaMD
@p_ciracimd
@DraMartinezLago
@DaisukeKotani
@Aiims1742
@ARosen380
@realbowtiedoc
@KoheiShitara
@MarioBalsaMD
Carlos Eugenio retweeted
📢 All new Rad Onc Student Scan!
🔗 Find it now from the RadOnc Student Scan: zurl.co/Jo5Q2
✔️ Get industry insights
✔️ Read up on hot topics in rad onc
✔️ Check out the virtual rounds
✔️ Find career development opportunities
#RadOnc #RadiationOncology #RadOncEd
Carlos Eugenio retweeted
Case of the Day ➡️ zurl.co/TBmvi
Radiation Recall Dermatitis with Docetaxel and Cyclophosphamide in a Case of Early Stage Breast Cancer Considered High Risk
The patient was a 55-year-old woman with an unremarkable history, presenting with a screen-detected mass on the left breast. Biopsy revealed grade II invasive ductal carcinoma, ER/PR-positive, HER2/neu-negative, and a Ki-67 of 5%.
#RadOnc #RadiationOncology #CancerCare #CaseStudy #RadOncEd #MedEd #CaseReport #CaseStudy
⚠️ Content Note: This post contains medical images that may be graphic. Shared for educational purposes in radiation oncology.
Carlos Eugenio retweeted
ARTROSIS de cadera o rodilla? Cirugía con ROBOT
La PRÓTESIS ROBÓTICA con ROBOT ROSA te cambia la vida.
- Precisión 99,9%
- Recuperación inmediata (4-6 semanas)
- Mínimo dolor (rehabilitación robótica)
Consulta☎️ 0999 055 059
UIO-Citimed
ESTRO clinical practice #guideline on high-dose thoracic #reirradiation for non-small cell #lungcancer: abstract published in the #GreenJournal.
👉 bit.ly/4yuCJdR
#radonc #radiotherapy #NSCLC
Carlos Eugenio retweeted
Editorial PCNSL
Low dose WBRT:
· Better cognitive outcomes (due to better CNS control?)
· >60yo OS benefit
· Consider LD-WBRT if not good transplant candidate
· LD-WBRT is a modern consolidative therapy
Contact your NCCN Reps to fix guidelines
sciencedirect.com/science/ar…
Carlos Eugenio retweeted
How to focal boost in prostate cancer radiotherapy: ESTRO clinical practice
consensus recommendations
sciencedirect.com/science/ar…
@RO_GreenJournal @ElsevierConnect
Carlos Eugenio retweeted
New ESTRO guideline ✅
High-dose thoracic reirradiation for non-small cell lung cancer - @RO_GreenJournal @ESTRO_RT
👉🏻Patient selection is probably the most important step (ECOG 0–1, life expectancy >6 months, MDT discussion).
👉🏻Wait > 6 months after the first course of thoracic RT before reRT.
👉🏻PET/CT + brain MRI before reRT, and biopsy if possible.
👉🏻No elective nodal irradiation.
👉🏻For peripheral tumors ≤5 cm, SBRT with BED₁₀ ≥100 Gy is preferred.
👉🏻If SBRT isn’t an option, 55 Gy/20 fx or 60 Gy/30 fx are reasonable.
👉🏻Assess cumulative OAR doses using EQD2, but the guideline doesn’t introduce new cumulative dose limits.
👉🏻Tissue recovery after the first RT is still uncertain, so cumulative dose assessment should be done with caution.
🔗 thegreenjournal.com/article/…
Carlos Eugenio retweeted
New in #practicalRO: Do Uniform Fasting Instructions Lead to Reproducible Stomach Volumes in Patients Being Treated With Radiation to the Pancreas? #radonc tinyurl.com/proevnguyen
🏆 Best Brachytherapy Paper at #ESTRO26
10-yr SiFEBI trial results show single-fraction #brachytherapy is safe & effective for elderly patients with low-risk #breastcancer.
✅ 5% local recurrence
✅ 0 cancer-related deaths
👉 bit.ly/4f66sB2
#RadOnc #radiotherapy
